AI assistant
Sending…
CVC LIMITED — Major Shareholding Notification 2012
Jul 26, 2012
64728_rns_2012-07-26_132bee89-f080-4976-83d3-d446e6b8ff99.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
605 page 1/2 15 July 2001
| 605page 1/2 15 July 2001 | |
|---|---|
| Form 605Corporations Act 2001Section 671BNotice of ceasing to be a substantial holder | |
To Company Name/SchemeACN/ARSN1. Details of substantial holder(1)NameACN/ARSN (if applicable)The holder ceased to be asubstantial holder on/ /The previous notice was given to the company on/ /The previous notice was dated/ /2. Changes in relevant interestsParticulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since thesubstantial holder was last required to give a substantial holding notice to the company or scheme are as follows:Date ofPerson whoseNature ofConsiderationClass (6) andPerson's voteschangerelevant interestchange (4)given in relationnumber ofaffectedchangedto change(5)securitiesaffected3. Changes in associationThe persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to votinginterests in the company or scheme are as follows:Name and ACN/ARSN (if applicable)Nature of association4. AddressesThe addresses of persons named in this form are as follows:NameAddressSignatureprint namecapacitysign heredate//Dolomatrix International Limited ("DMX")009 140 550CVC Limited ("CVC")002 700 36127 07 1207 06 1207 06 1227/7/2012 CVC LimitedDisposal$341,3312635076926,350,769On-marketCVC LimitedLevel 42, 259 George St, Sydney, NSWJohn HunterSecretary270712 |
More from CVC LIMITED
Board/Management Information
2026
May 18
Regulatory Filings
2026
May 17
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 30
Interest Rate Update/Notice
2026
Mar 23
Notice of Dividend Amount
2026
Mar 16
Notice of Dividend Amount
2026
Mar 16
Regulatory Filings
2026
Mar 8
Capital/Financing Update
2026
Feb 25
Interim / Quarterly Report
2026
Feb 23